EP1375652A3 - Orale Zusammensetzung für HIV-Infizierte - Google Patents

Orale Zusammensetzung für HIV-Infizierte Download PDF

Info

Publication number
EP1375652A3
EP1375652A3 EP03254087A EP03254087A EP1375652A3 EP 1375652 A3 EP1375652 A3 EP 1375652A3 EP 03254087 A EP03254087 A EP 03254087A EP 03254087 A EP03254087 A EP 03254087A EP 1375652 A3 EP1375652 A3 EP 1375652A3
Authority
EP
European Patent Office
Prior art keywords
oral compositions
hiv
infected subjects
methods
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03254087A
Other languages
English (en)
French (fr)
Other versions
EP1375652A2 (de
Inventor
Ling Yuk Cheung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ultra Biotech Ltd
Original Assignee
Ultra Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ultra Biotech Ltd filed Critical Ultra Biotech Ltd
Publication of EP1375652A2 publication Critical patent/EP1375652A2/de
Publication of EP1375652A3 publication Critical patent/EP1375652A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EP03254087A 2002-06-28 2003-06-27 Orale Zusammensetzung für HIV-Infizierte Withdrawn EP1375652A3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/184,749 US20040005335A1 (en) 2002-06-28 2002-06-28 Oral compositions for HIV-infected subjects
US184749 2002-06-28

Publications (2)

Publication Number Publication Date
EP1375652A2 EP1375652A2 (de) 2004-01-02
EP1375652A3 true EP1375652A3 (de) 2004-01-07

Family

ID=29717976

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03254087A Withdrawn EP1375652A3 (de) 2002-06-28 2003-06-27 Orale Zusammensetzung für HIV-Infizierte

Country Status (4)

Country Link
US (2) US20040005335A1 (de)
EP (1) EP1375652A3 (de)
CN (1) CN1275603C (de)
AU (1) AU2003204776A1 (de)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913913B2 (en) 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating renal failure
US6913914B2 (en) 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating hepatitis B
US6964864B2 (en) 2003-11-18 2005-11-15 Ultra Biotech Limited Methods and compositions for treating gastritis
US6977168B2 (en) 2003-11-18 2005-12-20 Ultra Biotech Limited Methods and compositions for treating nephrotic syndrome
US7078202B2 (en) 2003-11-18 2006-07-18 Ultra Biotech Limited Methods and compositions for treating vascular dementia
US7208159B2 (en) 2003-11-18 2007-04-24 Ultra Biotech Limited Methods and compositions for treating gastroparesis
US7259001B2 (en) 2003-11-18 2007-08-21 Ultra Biotech Limited Methods and compositions for treating male sexual dysfunction
US7297522B2 (en) 2003-11-18 2007-11-20 Ultra Biotech Limited Methods and compositions for treating epilepsy

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416982B1 (en) * 2000-09-05 2002-07-09 Ultra Biotech Ltd. Biological fertilizer based on yeasts
US6596272B2 (en) * 2001-03-01 2003-07-22 Ultra Biotech Limited Biological fertilizer compositions comprising poultry manure
US6828132B2 (en) * 2001-03-01 2004-12-07 Ultra Biotech Limited Biological fertilizer compositions comprising garbage
US6596273B2 (en) * 2001-03-01 2003-07-22 Ultra Biotech Limited Biological fertilizer compositions comprising swine manure
US20020123127A1 (en) * 2001-03-01 2002-09-05 Cheung Ling Y. Methods and compositions for reducing odor
US20020123130A1 (en) * 2001-03-01 2002-09-05 Cheung Ling Y. Methods and compositions for degrading polymeric compounds
US20020123129A1 (en) * 2001-03-01 2002-09-05 Cheung Ling Y. Methods and compositions for degrading nitrogen-containing compounds
US20030230245A1 (en) * 2002-06-18 2003-12-18 Cheung Ling Yuk Feed additives for reducing odor of animal waste products
US20040001812A1 (en) * 2002-06-18 2004-01-01 Ling Yuk Cheung Feed additives for ducks
US20030235567A1 (en) * 2002-06-18 2003-12-25 Cheung Ling Yuk Feed additives for cats
US20030235565A1 (en) * 2002-06-18 2003-12-25 Cheung Ling Yuk Feed additives for shrimp culture
US20030232059A1 (en) * 2002-06-18 2003-12-18 Ling Yuk Cheung Feed additives for fishes
US20030232039A1 (en) * 2002-06-18 2003-12-18 Cheung Ling Yuk Feed additives for crustaceans
US20030235569A1 (en) * 2002-06-18 2003-12-25 Ling Yuk Cheung Feed additives for chickens
US20030235568A1 (en) * 2002-06-18 2003-12-25 Cheung Ling Yuk Feed additives for dogs
US20030235566A1 (en) * 2002-06-18 2003-12-25 Cheung Ling Yuk Feed additives for animals: prevention of foot and mouth disease
US20030232038A1 (en) * 2002-06-18 2003-12-18 Cheung Ling Yuk Feed additives for cattle: prevention of E. coli infection
US7256026B2 (en) 2002-06-28 2007-08-14 Ultra Biotech Limited Oral compositions for white blood cell activation and proliferation
US20040005336A1 (en) * 2002-06-28 2004-01-08 Cheung Ling Yuk Dietary supplements for regulating the central nervous system
US20040005335A1 (en) * 2002-06-28 2004-01-08 Cheung Ling Yuk Oral compositions for HIV-infected subjects
WO2004108919A1 (en) * 2003-06-11 2004-12-16 Ultra Biotech Limited Biological compositions comprising yeast cells and methods for treatment of cancer
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) * 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US6984508B2 (en) * 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US7204988B2 (en) * 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US7223401B2 (en) * 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US6989253B2 (en) * 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7223402B2 (en) * 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) * 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US7214377B2 (en) * 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US20050106704A1 (en) * 2003-11-18 2005-05-19 Cheung Ling Y. Methods and compositions for treating lupus erythematosus
US20050106705A1 (en) * 2003-11-18 2005-05-19 Cheung Ling Y. Methods and compositions for treating hyperlipemia
PL1731596T3 (pl) * 2005-06-09 2013-08-30 Gnosis Spa Suszone, liofilizowane i/lub mikrokapsułkowane komórki Saccharomyces cerevisiae o dużej zawartości (S)-(+)-S-adenozylo-L-metioniny

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679793A (en) * 1970-02-13 1972-07-25 Stanley Drug Products Inc Method of raising the white blood cell count
US5504079A (en) * 1989-09-08 1996-04-02 Alpha-Beta Technology, Inc. Method for immune system activation by administration of a β(1-3) glucan which is produced by Saccharomyces cerevisiae strain R4
US6391619B1 (en) * 2001-03-01 2002-05-21 Ultra Biotech Limited Methods and compositions for suppressing growth of algae
WO2002062983A1 (fr) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited Levure faisant preuve d'une activite immunoregulatrice des lymphocytes t, son procede de preparation et ses applications
WO2002062985A1 (fr) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited Levure faisant preuve d'un activite immunoregulatrice cellulaire nk, son procede de preparation et ses applications
WO2002062982A1 (fr) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications
WO2002062981A1 (fr) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited Immunoregulateur humain de levure et son procede de preparation
WO2002062984A1 (en) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2107830A (en) * 1932-04-12 1938-02-08 Liebesny Paul Method of influencing enzymes and technically useful micro-organisms and the like
US4348483A (en) * 1981-01-23 1982-09-07 Universal Foods Corporation Method for the production of chromium yeast
US6143731A (en) * 1989-10-20 2000-11-07 The Collaborative Group, Ltd. Glucan dietary additives
FR2711528B1 (fr) * 1993-10-25 1996-02-09 Biocodex Lab Utilisation de levures Saccharomyces pour la fabrication d'un médicament contre la cryptosporidiose.
US6197295B1 (en) * 1996-09-25 2001-03-06 Viva America Marketing Corporation Dietary supplementation with, and methods for administration of yeast-derived selenium product
US6225113B1 (en) * 1998-12-04 2001-05-01 Genvec, Inc. Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene in an at least E4-deficient adenovirus
WO2002020431A1 (en) * 2000-09-05 2002-03-14 Ultra Biotech Limited A biological fertilizer based on yeasts
US6416982B1 (en) * 2000-09-05 2002-07-09 Ultra Biotech Ltd. Biological fertilizer based on yeasts
US6919207B2 (en) * 2001-01-25 2005-07-19 The Trustees Of Columbia University In The City Of New York Method for regulating genes with electromagnetic response elements
US6391618B1 (en) * 2001-03-01 2002-05-21 Ultra Biotech Limited Methods and compositions for degrading environmental toxins
US6391617B1 (en) * 2001-03-01 2002-05-21 Ultra Biotech Limited Yeast compositions for converting bio-available nitrogen in a culture medium to intracellular nitrogen
US20020123130A1 (en) * 2001-03-01 2002-09-05 Cheung Ling Y. Methods and compositions for degrading polymeric compounds
US6761886B2 (en) * 2001-03-01 2004-07-13 Ultra Biotech Limited Biological fertilizer compositions comprising cattle manure
US6596272B2 (en) * 2001-03-01 2003-07-22 Ultra Biotech Limited Biological fertilizer compositions comprising poultry manure
US6596273B2 (en) * 2001-03-01 2003-07-22 Ultra Biotech Limited Biological fertilizer compositions comprising swine manure
US20020123129A1 (en) * 2001-03-01 2002-09-05 Cheung Ling Y. Methods and compositions for degrading nitrogen-containing compounds
US6828132B2 (en) * 2001-03-01 2004-12-07 Ultra Biotech Limited Biological fertilizer compositions comprising garbage
US6436695B1 (en) * 2001-03-01 2002-08-20 Ultra Biotech Limited Yeast compositions for converting bio-available phosphorus in a culture medium to intracellular phosphorus
US6440713B1 (en) * 2001-03-01 2002-08-27 Ultra Biotech Limited Methods and compositions for suppressing growth of pathogenic microbes
US6800466B2 (en) * 2001-03-01 2004-10-05 Ultra Biotech Limited Biological fertilizer compositions comprising sludge
US20020123127A1 (en) * 2001-03-01 2002-09-05 Cheung Ling Y. Methods and compositions for reducing odor
US20030230245A1 (en) * 2002-06-18 2003-12-18 Cheung Ling Yuk Feed additives for reducing odor of animal waste products
US20030235565A1 (en) * 2002-06-18 2003-12-25 Cheung Ling Yuk Feed additives for shrimp culture
US20030232039A1 (en) * 2002-06-18 2003-12-18 Cheung Ling Yuk Feed additives for crustaceans
US20030235566A1 (en) * 2002-06-18 2003-12-25 Cheung Ling Yuk Feed additives for animals: prevention of foot and mouth disease
US20030235570A1 (en) * 2002-06-18 2003-12-25 Ling Yuk Cheung Feed additives for cattle
US20040001814A1 (en) * 2002-06-18 2004-01-01 Cheung Ling Yuk Feed additives for pigs
US20030235569A1 (en) * 2002-06-18 2003-12-25 Ling Yuk Cheung Feed additives for chickens
US20040001812A1 (en) * 2002-06-18 2004-01-01 Ling Yuk Cheung Feed additives for ducks
US20030235568A1 (en) * 2002-06-18 2003-12-25 Cheung Ling Yuk Feed additives for dogs
US20030232059A1 (en) * 2002-06-18 2003-12-18 Ling Yuk Cheung Feed additives for fishes
US20030235567A1 (en) * 2002-06-18 2003-12-25 Cheung Ling Yuk Feed additives for cats
US20030232038A1 (en) * 2002-06-18 2003-12-18 Cheung Ling Yuk Feed additives for cattle: prevention of E. coli infection
US20040001813A1 (en) * 2002-06-18 2004-01-01 Ling Yuk Cheung Feed additives for sheep
US20040005336A1 (en) * 2002-06-28 2004-01-08 Cheung Ling Yuk Dietary supplements for regulating the central nervous system
US20040005335A1 (en) * 2002-06-28 2004-01-08 Cheung Ling Yuk Oral compositions for HIV-infected subjects
US6759055B2 (en) * 2002-06-28 2004-07-06 Ultra Biotech Limited Dietary supplements for improving kidney function
US20040001857A1 (en) * 2002-06-28 2004-01-01 Cheung Ling Yuk Dietary supplements for treating hypertension
US6660508B1 (en) * 2002-06-28 2003-12-09 Ultra Biotech Limited Dietary supplements for treating hyperlipemia
US6709849B2 (en) * 2002-06-28 2004-03-23 Ultra Biotech Limited Dietary supplements for regulating male hormone
US6753008B2 (en) * 2002-06-28 2004-06-22 Ultra Biotech Limited Dietary supplements beneficial for the liver
US6756050B2 (en) * 2002-06-28 2004-06-29 Ultra Biotech Limited Dietary supplements for improving memory
US20040001859A1 (en) * 2002-06-28 2004-01-01 Cheung Ling Yuk Anti-aging dietary supplements
US6793933B2 (en) * 2002-06-28 2004-09-21 Ultra Biotech Limited Dietary supplements for enhancing the immune system
US7256026B2 (en) * 2002-06-28 2007-08-14 Ultra Biotech Limited Oral compositions for white blood cell activation and proliferation
US7204988B2 (en) * 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) * 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7208158B2 (en) * 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) * 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US6989253B2 (en) * 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7223405B2 (en) * 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US6987012B2 (en) * 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6984508B2 (en) * 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US7223400B2 (en) * 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7201906B2 (en) * 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204986B2 (en) * 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) * 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) * 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) * 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) * 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) * 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US6984507B2 (en) * 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US7223402B2 (en) * 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US20040265990A1 (en) * 2003-06-30 2004-12-30 Cheung Ling Yuk Biological compositions for reduction of E. coli infections
US6977168B2 (en) * 2003-11-18 2005-12-20 Ultra Biotech Limited Methods and compositions for treating nephrotic syndrome
US7259001B2 (en) * 2003-11-18 2007-08-21 Ultra Biotech Limited Methods and compositions for treating male sexual dysfunction
US20050106705A1 (en) * 2003-11-18 2005-05-19 Cheung Ling Y. Methods and compositions for treating hyperlipemia
US6913914B2 (en) * 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating hepatitis B
US20050106704A1 (en) * 2003-11-18 2005-05-19 Cheung Ling Y. Methods and compositions for treating lupus erythematosus
US6979562B2 (en) * 2003-11-18 2005-12-27 Ultra Biotech Limited Methods and compositions for treating gastroparesis
US20050106166A1 (en) * 2003-11-18 2005-05-19 Cheung Ling Y. Methods and compositions for treating liver cirrhosis
US7297522B2 (en) * 2003-11-18 2007-11-20 Ultra Biotech Limited Methods and compositions for treating epilepsy
US7078202B2 (en) * 2003-11-18 2006-07-18 Ultra Biotech Limited Methods and compositions for treating vascular dementia
US6913913B2 (en) * 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating renal failure
US6964864B2 (en) * 2003-11-18 2005-11-15 Ultra Biotech Limited Methods and compositions for treating gastritis

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679793A (en) * 1970-02-13 1972-07-25 Stanley Drug Products Inc Method of raising the white blood cell count
US5504079A (en) * 1989-09-08 1996-04-02 Alpha-Beta Technology, Inc. Method for immune system activation by administration of a β(1-3) glucan which is produced by Saccharomyces cerevisiae strain R4
WO2002062983A1 (fr) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited Levure faisant preuve d'une activite immunoregulatrice des lymphocytes t, son procede de preparation et ses applications
WO2002062985A1 (fr) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited Levure faisant preuve d'un activite immunoregulatrice cellulaire nk, son procede de preparation et ses applications
WO2002062982A1 (fr) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications
WO2002062981A1 (fr) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited Immunoregulateur humain de levure et son procede de preparation
WO2002062984A1 (en) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof
US6391619B1 (en) * 2001-03-01 2002-05-21 Ultra Biotech Limited Methods and compositions for suppressing growth of algae

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BINNINGER D M ET AL: "Effects of 60Hz AC magnetic fields on gene expression following exposure over multiple cell generations using Saccharomyces cerevisiae", BIOELECTROCHEMISTRY AND BIOENERGETICS, XX, XX, vol. 43, no. 1, 1997, pages 83 - 89, XP002223047, ISSN: 0302-4598 *
BOGAERDE VAN DEN J ET AL: "Immune sensitization to food, yeast and bacteria in Crohn's disease", ALIMENTARY PHARMACOLOGY & THERAPEUTICS, BLACKWELL SCIENTIFIC PUBLICATIONS LTD., CAMBRIDGE, GB, vol. 15, no. 10, October 2001 (2001-10-01), pages 1647 - 1653, XP002253929, ISSN: 0269-2813 *
DATABASE WPI Section Ch Week 200267, Derwent World Patents Index; Class B04, AN 2002-627546, XP002259468 *
DATABASE WPI Section Ch Week 200267, Derwent World Patents Index; Class B04, AN 2002-627547, XP002259469 *
DATABASE WPI Section Ch Week 200267, Derwent World Patents Index; Class B04, AN 2002-627548, XP002259470 *
DATABASE WPI Section Ch Week 200267, Derwent World Patents Index; Class B04, AN 2002-627549, XP002259471 *
DATABASE WPI Section Ch Week 200267, Derwent World Patents Index; Class B04, AN 2002-627550, XP002259472 *
GOODMAN E M ET AL: "EFFECTS OF ELECTROMAGNETIC FIELDS ON MOLECULES AND CELLS", INTERNATIONAL REVIEW OF CYTOLOGY, ACADEMIC PRESS, NEW YORK, US, vol. 158, 1995, pages 279 - 338, XP001119015, ISSN: 0074-7596 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913913B2 (en) 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating renal failure
US6913914B2 (en) 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating hepatitis B
US6964864B2 (en) 2003-11-18 2005-11-15 Ultra Biotech Limited Methods and compositions for treating gastritis
US6977168B2 (en) 2003-11-18 2005-12-20 Ultra Biotech Limited Methods and compositions for treating nephrotic syndrome
US7078202B2 (en) 2003-11-18 2006-07-18 Ultra Biotech Limited Methods and compositions for treating vascular dementia
US7208159B2 (en) 2003-11-18 2007-04-24 Ultra Biotech Limited Methods and compositions for treating gastroparesis
US7259001B2 (en) 2003-11-18 2007-08-21 Ultra Biotech Limited Methods and compositions for treating male sexual dysfunction
US7297522B2 (en) 2003-11-18 2007-11-20 Ultra Biotech Limited Methods and compositions for treating epilepsy

Also Published As

Publication number Publication date
CN1275603C (zh) 2006-09-20
US20040005335A1 (en) 2004-01-08
AU2003204776A1 (en) 2004-01-22
US20070041995A1 (en) 2007-02-22
CN1481824A (zh) 2004-03-17
EP1375652A2 (de) 2004-01-02

Similar Documents

Publication Publication Date Title
EP1375652A3 (de) Orale Zusammensetzung für HIV-Infizierte
EP1375651A3 (de) Orale Zusammensetzung zur Aktivierung und Proliferation von weissen Blutkörperchen
SI1427817T1 (sl) Razmnoževanje virusov in celičnih kultur
WO2003078455A3 (en) Virus like particle from papillomavirus and their use in vaccine
WO2004096818A3 (en) Method and compositions for identifying anti-hiv therapeutic compounds
IL202249A (en) Nucleic Acids Encoders Human Immunodeficiency Strange Type 1 (HIV – 1) Group M Consensus Envelope Glycoproteins
EP2258712A3 (de) Zusammensetzungen und Verfahren zur Einleitung bzw. Verstärkung von Antikörper- und Haupthistokompatibilität-Klasse-I- oder-Klasse-II-beschränkten T-Zell-Reaktionen unter Anwendung von Immunmodulierenden, nicht-codierenden RNA-Motiven
EP2684554A8 (de) Verwendung von Keramik in dental- und kieferorthopädischen Anwendungen
EP1541671A4 (de) Neue bäckerhefestämme und brot unter verwendung davon
EA200701633A1 (ru) Вакцина на основе вирусоподобных частиц вируса папилломы человека 16 и вируса папилломы человека 18 l1
MY134041A (en) Novel composition
WO2004037175A3 (en) Compositions and methods for treating human papillomavirus-mediated disease
WO2002077012A3 (en) Human papilloma virus immunoreative peptides
DE60037327D1 (de) Neues verfahren zur herstellung von virus-ähnlichen partikeln des menschen-papillomavirus mit verbesserten eigenschaften
Maki et al. The impact of race on tooth formation
EP1321478A3 (de) Antikörper gegen Streptococcus mutans und dessen Verwendung in einem Immuntest
EP1316318A3 (de) Verfahren zur Transduktion von Proteinen in Zellen
WO2005076001A3 (en) A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
EP1424075A3 (de) Säure und Gallensalz-resistente Lactobacillus Isolate, welche die Fähigkeit besitzen, Cholesterin zu erniedrigen oder zu assimilieren
CA2519012C (en) A method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual
WO2003091380A3 (en) Method for preparing tissue constructs
WO2006045616A3 (en) β-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES
WO2002048325A3 (en) Regulation of human serine palmitoyltransferase
DE60124725D1 (de) Herstellung eines chimeren papillomavirus
WO2006019841A3 (en) Treatment of viral infections with egr 1 activators

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1059947

Country of ref document: HK

17P Request for examination filed

Effective date: 20040608

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

17Q First examination report despatched

Effective date: 20070116

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090101

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1059947

Country of ref document: HK